Tolerability of Nab-Paclitaxel Plus Gemcitabine as Adjuvant Setting in Japanese Patients With Resected Pancreatic Cancer: Phase I Study

OBJECTIVE: The combination of gemcitabine plus nab-paclitaxel (GnP) has not been studied in Japanese patients with resectable pancreatic cancer (PC). This study aimed to assess the tolerability of adjuvant GnP in Japanese patients with resected PC. METHODS: This was a Phase I, open-label, multicente...

Full beskrivning

Sparad:
Bibliografiska uppgifter
I publikationen:Pancreas
Huvudupphovsmän: Ueno, Makoto, Morinaga, Soichiro, Hashimoto, Yusuke, Umemoto, Kumiko, Sasahira, Naoki, Saiura, Akio, Seyama, Yasuji, Honda, Goro, Ioka, Tatsuya, Takahashi, Hidenori, Miyamoto, Atsushi, Nakamori, Shoji, Unno, Michiaki, Takadate, Tatsuyuki, Mizuno, Nobumasa, Shimizu, Yasuhiro, Ueno, Hideki, Sugiyama, Masanori, Fukutomi, Akira, Shimizu, Satoshi, Okusaka, Takuji, Furuse, Junji
Materialtyp: Artigo
Språk:Inglês
Publicerad: Lippincott Williams & Wilkins 2021
Ämnen:
Original Articles
Länkar:https://ncbi.nlm.nih.gov/pmc/articles/PMC7748052/
https://ncbi.nlm.nih.gov/pubmed/33370027
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/MPA.0000000000001702
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!

Liknande verk